Researchers in Britain have developed the world's most effective malaria vaccine, with it becoming the first to achieve the World Health Organisation-specified 75 percent efficacy goal. The second, called P. vivax, is the predominant parasite in the Region of the Americas, representing 75 percent of malaria cases. Most malaria cases and deaths occur in sub-Saharan Africa, but South-East Asia, Eastern Mediterranean, Western Pacific, and the Americas are also at risk. The first scientific report for a malaria vaccine was published in 1910, the first trial of a malaria vaccine took place in the 1940s, and 140 malaria vaccines have gone into clinical testing. 'We have been supporting trials of a range of new vaccine candidates in Burkina Faso and these new data show that licensure of a very useful new malaria vaccine could well happen in the coming years.

Source: Daily Mail April 23, 2021 04:03 UTC